Relative Biological Effectiveness
"Relative Biological Effectiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
| Descriptor ID |
D012062
|
| MeSH Number(s) |
N06.850.810.250.275
|
| Concept/Terms |
Relative Biological Effectiveness- Relative Biological Effectiveness
- Effectiveness, Biological Relative
- Biological Relative Effectiveness
- Effectiveness, Biologic Relative
- Biologic Relative Effectiveness
- Relative Effectiveness, Biologic
- Relative Biologic Effectiveness
- Biologic Effectiveness, Relative
- Effectiveness, Relative Biologic
- Biological Effectiveness, Relative
- Effectiveness, Relative Biological
|
Below are MeSH descriptors whose meaning is more general than "Relative Biological Effectiveness".
Below are MeSH descriptors whose meaning is more specific than "Relative Biological Effectiveness".
This graph shows the total number of publications written about "Relative Biological Effectiveness" by people in this website by year, and whether "Relative Biological Effectiveness" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Relative Biological Effectiveness" by people in Profiles.
-
Lan J, Li R, Yin LM, Deng L, Gui J, Chen BQ, Zhou L, Meng MB, Huang QR, Mo XM, Wei YQ, Lu B, Dicker A, Xue JX, Lu Y. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):74-87.
-
Ohri N, Werner-Wasik M, Grills IS, Belderbos J, Hope A, Yan D, Kestin LL, Guckenberger M, Sonke JJ, Bissonnette JP, Xiao Y. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e379-84.
-
Ohri N, Dicker AP, Lawrence YR. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):385-93.
-
Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, L?tourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):107-16.
-
Bednarz G, Michalski D, Anne PR, Valicenti RK. Inverse treatment planning using volume-based objective functions. Phys Med Biol. 2004 Jun 21; 49(12):2503-14.
-
Koh WJ, Laramore G, Griffin T, Russell K, Griffin B, Parker R, Davis L, Pajak TF. Fast neutron radiation for inoperable and recurrent salivary gland cancers. Am J Clin Oncol. 1989 Aug; 12(4):316-9.